Lerisetron

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLerisetron
Drug Alias Namelerisetronum来立司琼F-0930RSF-0930
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsVomitingNauseaGerminoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFaes Farma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSimbec Research Ltd
Active IndicationsN/A
Inactive IndicationsVomitingNauseaGerminoma

Other Information

ATC CodeN/A
Related LinksN/A